Efficient generation of highly functionalized fused oxazepine frameworks based on a CAN-catalyzed four-component tetrahydropyridine synthesis/ring- closing metathesis sequence

Journal of Organic Chemistry

Volumn 74, Issue 24, 2009, Pages 9365-9371

  Sridharan, Vellaisamy ^a   Maiti, Swarupananda ^a   Menéndez, J Carlos ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL EQUATIONS; ENYNE METATHESIS; FUNCTIONALIZED; METATHESIS REACTIONS; METATHESIS SEQUENCES; PROPARGYL; RING CLOSING METATHESIS; TETRAHYDROPYRIDINES;

SYNTHESIS (CHEMICAL);

AMMONIA; AMMONIUM CITRATE; DICHLOROMETHANE; OXAZEPINE DERIVATIVE; PYRIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ALKYLATION; ARTICLE; CATALYSIS; CHEMICAL REACTION; DIELS ALDER REACTION; RING CLOSING METATHESIS; SYNTHESIS;

ALKYNES; CATALYSIS; CERIUM; CYCLIZATION; MOLECULAR MIMICRY; NITRATES; OXAZEPINES; PYRIDINES;

EID: 73149118279     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo9021309     Document Type: Article

References (41)

1. For selected reviews of the role of peptidomimetics in drug design, see: (a) Giannis, A.; Rubsam, F. Adv. Drug. Res. 1997, 29, 1.
2. (b) Leung, D.; Abbenante, G.; Fairlie, D. P. J. Med. Chem. 2000, 43, 305.
3. (c) Goodman, M.; Zapf, C.; Rew, Y. Pept. Sci 2001, 60, 229.
4. (d) Pérez, J. J.; Corcho, F.; Llorens, O. Curr. Med. Chem. 2002, 9, 2209.
5. (e) Estiarte, M. A.; Rich, D. H. In Burger's Medicinal Chemistry and Drug Discovery, 6th ed.; Abraham, D. J., Ed.; Wiley-Interscience: New York, 2003; Vol. 1, p 633.
6. (f) Avendaño, C.; Menéndez, J. C. Clin. Transl. Oncol. 2007, 9, 563.
7. (g) Clynen, E.; Baggerman, G.; Husson, S. J.; Landuyt, B.; Schoofs, L. Expert Opin. Drug Discov. 2008, 3, 425.
8. (a) Robl, J. A. US Patent 5,508,272A (Apr 16, 1996).
9. (b) Robl, J. A.; Sun, C.-Q.; Stevenson, J.; Ryono, D. E.; Simpkins, L. M.; Cimarusti, M. P.; Dejneka, T.; Slusarchyk, W. A.; Chao, S.; Stratton, L.; Misra, R. N.; Bednarz, M. S.; Asaad, M. M.; Cheung, H. S.; Abboa-Offei, B. E.; Smith, P. L.; Mathers, P. D.; Fox, M.; Schaeffer, T. R.; Seymour, A. A.; Trippodo, N. C. J. Med. Chem. 1997, 40, 1570.
10. Chiou, W.-H.; Mizutani, N.; Ojima, I. J. Org. Chem. 2007, 72, 1871.
11. Sridharan, V.; Maiti, S.; Menéndez, J. C. Chem. - Eur. J. 2009, 15, 4565.
12. For some reviews of cerium ammonium nitrate-promoted synthetic transformations, see: (a) Nair, V.; Matthew, J.; Prabhakaran, J. Chem. Soc. Rev. 1997, 127.
13. (b)Hwu, J. R.; King, K.-Y. Curr. Sci. 2001, 81, 1043.
14. (c) Nair, V.; Panicker, S. B.; Nair, L. G.; George, T. G.; Augustine, Z. Synlett 2003, 156.
15. (d) Nair, V.; Balagopal, L.; Rajan, R.; Mathew, J. Acc. Chem. Res. 2004, 37, 21.
16. (e) Nair, V.; Deepthi, A. Chem. Rev. 2007, 107, 1862.
17. For representative recent examples of CAN-catalyzed reactions, taken from the work of our group, see: (a) Sridharan, V.; Ribelles, P.; Ramos, M. T.; Menéndez, J. C. J. Org. Chem. 2009, 74, 5715.
18. (b) Sridharan, V.; Avendaño, C.; Menéndez, J. C. Tetrahedron 2009, 65, 2087.
19. (c) Sridharan, V.; Menéndez, J. C. Org. Lett. 2008, 10, 4303.
20. (d) Sridharan, V.; Avendaño, C.; Menéndez, J. C. Synthesis 2008, 1039.
21. (e) Sridharan, V.; Avendaño, C.; Menéndez, J. C. Synlett 2007, 1079.
22. (f) Sridharan, V.; Avendaño, C.; Menéndez, J. C. Synlett 2007, 881.
23. (g) Sridharan, V.; Avendaño, C.; Menéndez, J. C. Tetrahedron 2007, 63, 4407.
24. (h) Sridharan, V.; Avendaño, C.; Menéndez, J. C. Tetrahedron 2007, 63, 673.
25. (i) See also ref 4.
26. For a review of the synthesis of oxygen and nitrogen heterocycles using ring-closing metathesis reactions, see: Deiters, A.; Martin, S. F. Chem. Rev. 2004, 104, 2199.
27. For examples of the synthesis of 1,2-oxazepines by ring-closing metathesis, see: (a) Koide, K.; Finkelstein, J. M.; Ball, Z.; Verdine, G. L. J. Am. Chem. Soc. 2001, 123, 398.
28. (b) Van der Jeught, S.; Stevens, C. V.; Dieltiens, N. Synlett 2007, 3183.
29. For a review of enyne metathesis, see: Diver, S. T.; Giessert, A. J. Chem. Rev. 2004, 104, 1317-1382.
30. Maiti, S.; Menéndez, J. C. Synlett 2009, 2249.
31. For the acceleration of RCEYM reactions in the presence of ethylene, see: (a) Mori, M.; Sakakibara, N.; Kinoshita, A. J. Org. Chem. 1998, 63, 6082.
32. For representative examples of the synthetic application of this protocol, see ref 4 and: (b) Saito, N.; Sato, Y.; Mori, M. Org. Lett. 2002, 3, 803.
33. (c)Núñez, A.; Cuadro, A. M.; Álvarez-Builla, J.; Vaquero, J. J. Chem. Commun. 2006, 2690.
34. (a) Royer, F.; Vilain, C.; Elkaïm, L.; Grimaud, L. Org. Lett. 2003, 5, 2007.
35. (b) Lee, H.-Y.; Kim, H. Y.; Tae, H.; Kim, B. G.; Lee, J. Org. Lett. 2003, 5, 3439.
36. Ma, S.; Ni, B.; Liang, Z. J. Org. Chem. 2004, 69, 6305.
37. For a review of the synthetic applications of the RCEYM/ Diels-Alder sequence, see: Kotha, S.; Meshram, M.; Tiwari, A. Chem. Soc. Rev. 2009, 38, 2065.
38. (a) De Kok, P. M. T.; Bastiaansen, L. A. M.; Van Lier, P. M.; Vekemans, J. A. J. M.; Buck, H. M. J. Org. Chem. 1989, 54, 1313.
39. (b) Caballero, E.; Puebla, P.; Medarde, M.; San Feliciano, A. Tetrahedron 1993, 49, 10079-10088.
40. (c) Noël, R.; Vanucci-Bacqué, C.; Fargeau-Bellassoued, M.-C.; Lhommet, G. J. Org. Chem. 2005, 70, 9044.
41. Noël, R.; Fargeau-Bellassoued, M.-C.; Vanucci-Bacqué, C.; Lhommet, G. Synthesis 2008, 1948.